Global Nanotechnology in Drug Delivery Market - 2019-2026
|藥物輸送奈米技術的全球市場:2019年∼2026年 Global Nanotechnology in Drug Delivery Market - 2019-2026|
|出版日期: 按訂單生產||內容資訊: 英文||
Nanotechnology in drug delivery is the rapidly developing way of providing effective treatment for the various diseases. The nanotechnology based drugs can have the potential to deliver the drugs at targeted and affected parts of the human body by reducing the side effects. Nanotechnology drug delivery utilizes the nanoscale range nanoparticles like liposomes, chemotherapeutic agents, biological agents etc to deliver the therapeutic agents to specific targeted sites in a controlled manner. The nanotechnology drug delivery has certain benefits including improve the ability to deliver drugs that are poorly water soluble, reduce drug accumulation within healthy tissue, combine therapeutic and diagnostic modalities through one agent, transportation of drugs across epithelial and endothelial barriers, protection from the biological environment, effective treatment can be achieved by retaining the drug in the body long time. The global nanotechnology in drug delivery market valued USD XX million in 2018 and it is expected to grow at a CAGR of XX% to reach USD XX million by 2026.
The market is driven by the rising prevalence of the chronic ailments like cancer, tumor, heart disease, coronary artery disease due to unhealthy lifestyle and changing environment around the globe. According to World Health Organization in 2018, Cancer is the leading cause of death accounted for the 9.6 million people died around the globe and more than 300000 patients are being diagnosed each year. Nanomedicine plays vital role for enhancing the human health by reducing the side effects. Currently nanotechnology based drug delivery statins, nanoantibiotics and others agents can be utilized as a valid treatment for preventing certain diseases like cancer, coronary artery disease and many others. Nanoantibiotics will utilize this effect to enhance infection treatment via the application of both nanoparticles with antimicrobial therapies and nanosized biological molecules for improved antibiotic drug delivery.
There is a rise FDA approvals and surge in the development of the innovative drugs through extensive research and developments treatment of various diseases has created ample opportunity for this market. For instance on 17th June 2020, Nanobiotix Company had been received feedback plans for development of effective designed platinum based chemotherapy from the US FDA. The Company had started to advance Phase III clinical trials for the treatment of neck and head cancer based on chemistry, manufacturing and controls (CMC) development through necessary study design to support the future New Drug Application (NDA).
The global nanotechnology in drug delivery market is segmented based on technology, applications, and region.
In terms of technology type the global nanotechnology in drug delivery market is bifurcated into micelles, nanoparticles, liposomes, nanocrystals and others. Among these, nanoparticles segment has the highest market share in 2019 owing to increasing launching of advanced technology based nanoparticles for the effective treatment and avoiding the side effects due to harmful drugs. For instance on 5th Nov 2019, MIT engineers had been developed the nanoparticle coated with "right-handed" molecules orientation had been offered to enhance drug delivery.
Depending on technology type micelles, nanoparticles, liposomes, nanocrystals segments are also growing at faster pace owing to increasing the demand for the effective treatment drugs with rising launching of new nano-based medicine. For instance on 14th May 2020, , NanOlogy Company had been launched new drug delivery injection Nanopac for targeting the treatment of Pancreatic Cancer and Mucinous Cystic Neoplasms.
Depending on the applications, global nanotechnology in drug delivery market is divided into anti-infective, neurology, anti-inflammatory/immunology, oncology, cardiovascular/physiology, and others. Among this, anti-inflammatory/immunology segment has the highest share in 2019. This is primarily due to rising investment for the development of the new drugs for the immune system for various diseases. For instance Ventus launched Wednesday with $60 million from Versant Ventures and GV. Working out of dual headquarters in Waltham and Montreal, the biotech plans to create drugs that target the immune system's first line of defense, known as the innate immune system. For instance on 6th May 2020, Ventus Therapeutics Company had been received funding of the USD 60 Million to develop medicines that has been targeted the innate immune system.
Similarly, anti-infective, neurology, oncology, cardiovascular/physiology segments are also growing at faster pace owing to increase in the prevalence of the chronic ailments like cancer, cardiovascular, neurological diseases etc around the globe. According to the World Health Organization, an estimated 31% of all global deaths that is around 17.9 million people die each year due to the cardiovascular diseases. This propels the advanced treatment methods for the effective treatment of the diseases through the nanotechnology drug delivery systems.
By region, the global Nanotechnology in Drug Delivery market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America is the dominated region for the global nanotechnology in drug delivery market and expected to grow at the highest CAGR during the forecasted period due to presence of leading healthcare players' with presence of the advanced technology followed by Europe region. Furthermore, rising the prevalence of the chronic diseases like cancer, cardiovascular etc in this region due to unhealthy lifestyle and diet had propelled the demand for the nanotechnology in drug delivery market. According to the According to a recent study by American Cancer Society researchers, in the United 750000 cases were diagnosed that is at least 42% of cancers cases in 2020. This propels the demand for the electronics avionics market during the forecast period.
Asia Pacific is the also growing at faster pace for the nanotechnology in drug delivery market, owing to prevalence of the chronic diseases like cancer, cardiovascular etc. According to the Cancer Organization in 2018, Asia Pacific region has accounted for around for around 5.7 millions of cases were diagnosed and is projected to reach around 7.8 million new cancer cases by 2050. This will propel the demand for the advanced treatment for drug delivery through nanotechnology.
The global nanotechnology in drug delivery market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition. Ceramisphere Health Pvt Limited, Cristal Therapeutics, CYTIMMUNE SCIENCES, Inc., Nanobiotix, NanoCarrier Co. Ltd., NanOlogy LLC, EnColl Corporation, EyePoint Pharmaceuticals, AbbVie Inc., Aquanova AG, BlueWillow Biologics, Camurus AB, Celgene, Inc., Lena Nanoceutics Ltd.are the leading market players with significant market share.
There is rising FDA approval for the adoption of the advance technology like nanotechnology for the treatment of the various chronic diseases like cancer, cardiovascular diseases etc have created huge opportunity for this market. For instance on 9th June 2020, NanOlogy Company had started the clinical trials using nanotechnology based drug delivery devices like intratumoral (IT) injections of NanoPac for the treatment of lung cancer with FDA permission. Companies are entering into the collaborations, acquisitions, mergers, and licensing for increasing their market penetration.